PMID- 38290908
OWN - NLM
STAT- MEDLINE
DCOM- 20240319
LR  - 20240319
IS  - 1879-0267 (Electronic)
IS  - 0020-1383 (Linking)
VI  - 55
IP  - 4
DP  - 2024 Apr
TI  - The MCID of the PROMIS physical function instrument for operatively treated 
      tibial plateau fractures.
PG  - 111375
LID - S0020-1383(24)00062-7 [pii]
LID - 10.1016/j.injury.2024.111375 [doi]
AB  - INTRODUCTION: Understanding minimal clinically important differences (MCID) in 
      patient reported outcome measurement are important in improving patient care. The 
      purpose of this study was to determine the MCID of Patient-Reported Outcome 
      Measurement System (PROMIS) Physical Function (PF) domain for patients who 
      underwent operative fixation of a tibial plateau fracture. METHODS: All patients 
      with tibial plateau fractures that underwent operative fixation at a single level 
      1 trauma center were identified by Current Procedural Terminology codes. Patients 
      without PROMIS PF scores or an anchor question at two-time points postoperatively 
      were excluded. Anchor-based and distribution-based MCIDs were calculated. 
      RESULTS: The MCID for PROMIS PF scores was 4.85 in the distribution-based method 
      and 3.93 (SD 14.01) in the anchor-based method. There was significantly more 
      improvement in the score from the first postoperative score (<7 weeks) to the 
      second postoperative time (<78 weeks) in the improvement group 10.95 (SD 9.95) 
      compared to the no improvement group 7.02 (SD 9.87) in the anchor-based method 
      (P < 0.001). The percentage of patients achieving MCID at 7 weeks, 3 months, 6 
      months, and 1 year were 37-42 %, 57-62 %, 80-84 %, and 95-87 %, respectively. 
      DISCUSSION: This study identified MCID values for PROMIS PF scores in the tibial 
      plateau fracture population. Both MCID scores were similar, resulting in a 
      reliable value for future studies and clinical decision-making. An MCID of 3.93 
      to 4.85 can be used as a clinical and investigative standard for patients with 
      operative tibial plateau fractures.
CI  - Copyright (c) 2024 Elsevier Ltd. All rights reserved.
FAU - Thorne, Tyler J
AU  - Thorne TJ
AD  - University of Utah, Department of Orthopaedic Surgery, Salt Lake City, UT, USA.
FAU - Cizik, Amy M
AU  - Cizik AM
AD  - University of Utah, Department of Orthopaedic Surgery, Salt Lake City, UT, USA.
FAU - Kellam, Patrick J
AU  - Kellam PJ
AD  - University of Utah, Department of Orthopaedic Surgery, Salt Lake City, UT, USA.
FAU - Rothberg, David L
AU  - Rothberg DL
AD  - University of Utah, Department of Orthopaedic Surgery, Salt Lake City, UT, USA.
FAU - Higgins, Thomas F
AU  - Higgins TF
AD  - University of Utah, Department of Orthopaedic Surgery, Salt Lake City, UT, USA.
FAU - Dekeyser, Graham J
AU  - Dekeyser GJ
AD  - University of Washington, Department of Orthopaedic Surgery, Harborview Medical 
      Center, Seattle, WA, USA.
FAU - Haller, Justin M
AU  - Haller JM
AD  - University of Utah, Department of Orthopaedic Surgery, Salt Lake City, UT, USA. 
      Electronic address: justin.haller@hsc.utah.edu.
LA  - eng
PT  - Journal Article
DEP - 20240122
PL  - Netherlands
TA  - Injury
JT  - Injury
JID - 0226040
SB  - IM
MH  - Humans
MH  - *Tibial Plateau Fractures
MH  - Patient Reported Outcome Measures
MH  - Minimal Clinically Important Difference
MH  - *Tibial Fractures/surgery
MH  - Treatment Outcome
MH  - Retrospective Studies
OTO - NOTNLM
OT  - Functional outcome
OT  - MCID
OT  - PROMIS
OT  - Physical function
OT  - Psychometric analysis
OT  - Tibial plateau fracture
COIS- Declaration of competing interest Project as a whole: This investigation was 
      supported by the University of Utah Study Design and Biostatistics Center, with 
      funding in part from the National Center for Research Resources and the National 
      Center for Advancing Translational Sciences, National Institutes of Health, 
      through grant UL1TR002538 (formerly 5UL1TR001067- 05, 8UL1TR000105, and 
      UL1RR025764). Tyler Thorne: No funding disclosures or conflicts of interest 
      relevant to the current study. Amy Cizik: receives Extramural Loan Repayment 
      Program for Clinical Researchers through NIAMS 1 L30 AR077934-01. She has no 
      other funding discolusres or conflicts of interest relevant to the current study. 
      Patrick Kellam: No funding disclosures or conflicts of interest relevant to the 
      current study. David Rothberg: No funding disclosures or conflicts of interest 
      relevant to the current study. Thomas Higgins: is a paid consultant for DePuy 
      Synthes, Osteocentric, and Globus Medical. He has stock or stock options in 
      Imagen, NT nPhase, Orthogrid, and Osteocentric. He receives IP royalties from 
      DePuy, A Johnson & Johnson Company. He is a board or committee member of the 
      Orthopaedic Trauma Association. Graham Dekeyser: No funding disclosures or 
      conflicts of interest relevant to the current study. Justin Haller: is a paid 
      consultant for NewClip Technics, Osteocentric, and Stryker. He is a 
      board/committee member of the Orthopaedic Trauma Association, and Western 
      Orthopedic Association.
EDAT- 2024/01/31 00:42
MHDA- 2024/03/19 06:43
CRDT- 2024/01/30 22:00
PHST- 2023/12/11 00:00 [received]
PHST- 2024/01/16 00:00 [revised]
PHST- 2024/01/18 00:00 [accepted]
PHST- 2024/03/19 06:43 [medline]
PHST- 2024/01/31 00:42 [pubmed]
PHST- 2024/01/30 22:00 [entrez]
AID - S0020-1383(24)00062-7 [pii]
AID - 10.1016/j.injury.2024.111375 [doi]
PST - ppublish
SO  - Injury. 2024 Apr;55(4):111375. doi: 10.1016/j.injury.2024.111375. Epub 2024 Jan 
      22.